Clinical Trial Update: Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating telaprevir in HIV/Hepatitis C coinfected patients who previously failed peginterferon-ribavirin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Hepatitis C, Chronic, HIV Infection | Phase 2 | Status: COMPLETED